These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10025428)

  • 1. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?
    Kraft E; Schwarz J; Trenkwalder C; Vogl T; Pfluger T; Oertel WH
    Arch Neurol; 1999 Feb; 56(2):225-8. PubMed ID: 10025428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders.
    Wadia PM; Howard P; Ribeirro MQ; Robblee J; Asante A; Mikulis DJ; Lang AE
    Can J Neurol Sci; 2013 May; 40(3):389-402. PubMed ID: 23603177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation of atypical Parkinson syndrome and delineation from idiopathic Parkinson syndrome with routine magnetic resonance tomography].
    Csoti I; Warmuth-Metz M; Solymosi L; Becker Dagger G; Fornadi F; Naumann M
    Nervenarzt; 2004 Feb; 75(2):128-34. PubMed ID: 14770282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease.
    Kraft E; Trenkwalder C; Auer DP
    Neurology; 2002 Oct; 59(8):1265-7. PubMed ID: 12391363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
    Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putaminal hyperintensity on T1-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy.
    Ito S; Shirai W; Hattori T
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):689-92. PubMed ID: 19147717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study.
    Sugiyama A; Ito S; Suichi T; Sakurai T; Mukai H; Yokota H; Yonezu T; Kuwabara S
    J Neurol Sci; 2015 Feb; 349(1-2):174-8. PubMed ID: 25619571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2*-weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians.
    von Lewinski F; Werner C; Jörn T; Mohr A; Sixel-Döring F; Trenkwalder C
    J Neurol; 2007 Sep; 254(9):1184-8. PubMed ID: 17361340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy.
    Lee JY; Yun JY; Shin CW; Kim HJ; Jeon BS
    J Neurol; 2010 Dec; 257(12):2065-70. PubMed ID: 20652301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
    Reiter E; Mueller C; Pinter B; Krismer F; Scherfler C; Esterhammer R; Kremser C; Schocke M; Wenning GK; Poewe W; Seppi K
    Mov Disord; 2015 Jul; 30(8):1068-76. PubMed ID: 25773707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes.
    Stern MB; Braffman BH; Skolnick BE; Hurtig HI; Grossman RI
    Neurology; 1989 Nov; 39(11):1524-6. PubMed ID: 2812334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2-low signal intensity in the cortex in multiple system atrophy.
    Miwa H; Kajimoto Y; Nakanishi I; Morita S; Komoto J; Kihira T; Kondo T
    J Neurol Sci; 2003 Jul; 211(1-2):85-8. PubMed ID: 12767503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
    Asato R; Akiguchi I; Masunaga S; Hashimoto N
    J Neural Transm (Vienna); 2000; 107(12):1427-36. PubMed ID: 11458995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
    J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.